MCP server exposing 5 tools for china-pharma.
This URL is a JSON-RPC 2.0 endpoint over HTTP. Issue POST requests with a JSON-RPC body. Browsers and search crawlers land here on GET.
POST https://gateway.pipeworx.io/china-pharma/mcp
Content-Type: application/json
{"jsonrpc":"2.0","id":1,"method":"tools/list"}china_licensing_deals — Biotech and pharmaceutical licensing deals involving China — a Chinese company out-licensing a drug to a Western partner, or a Western company licensing rights INTO Greater China. Returns the two companies, the drug or asset, the territory, the upfront payment, milestone totals and royalty terms, with the SEC filing they were announced in and its date. Answers "which Chinese biotechs signed out-licensing deals", "recent China pharma licensing deals", "who licensed rights in Greater China". Sourced from SEC 8-K announcements, so it covers any deal with a US-listed party. Filter by company, drug name or date window.nmpa_updates — Official announcements from China's drug regulator, the NMPA (National Medical Products Administration) — regulatory policy changes, guidance documents, import rules, clinical-trial guideline updates and reform opinions, in English, straight from the regulator. Answers "latest NMPA regulatory updates", "what has China's drug regulator changed", "NMPA guidance on medical devices or cosmetics". Returns title, publication date and the announcement URL. NOTE: this is the announcements feed, NOT the drug-approval register — it does not list which drugs were approved.nmpa_drug_approvals — NMPA (国家药监局) drug-APPROVAL events — a specific drug cleared for marketing, granted conditional approval, or given an expanded indication in China — as opposed to nmpa_updates, which is regulatory policy news. 批准 新药 创新药 获批上市 NMPA新药批准. Answers "latest NMPA drug approvals in China", "2026年8月NMPA批准的新药", "what new drugs did China approve this month", "recent Chinese biotech drug approvals". Sourced from HKEX (Hong Kong Exchange) disclosure filings: any Hong Kong-listed biotech announces an NMPA approval as a regulatory disclosure the same day, and that filing is public and structured. Returns the filing headline (which names the drug and often the indication), the company, the approval date, a best-effort category, and the filing PDF. Coverage is limited to HKEX-listed companies — see coverage_note in the response.csrc_penalties — Administrative penalty decisions (行政处罚决定书) from the CSRC — the China Securities Regulatory Commission, China's securities and capital-markets regulator — newest first, straight from csrc.gov.cn's own JSON feed. Each row carries the decision number (e.g. 〔2026〕42号), the publication date, the named parties from the decision's opening lines (listed companies, accounting firms, individuals sanctioned for disclosure fraud, insider trading, market manipulation), and the link to the full decision. Answers "recent CSRC enforcement actions", "中国证监会最近的行政处罚", "which companies did China's securities regulator penalize". This is securities-market enforcement, not drug regulation — for NMPA announcements use nmpa_updates.nmpa_drug_approval — One NMPA drug-approval record by id (the `id` field returned by nmpa_drug_approvals) or by name (a drug name, code, or company). 单个药品批准记录. Returns the same fields as nmpa_drug_approvals for the single best-matching filing, plus the filing headline as a summary. Use nmpa_drug_approvals to browse first if you do not already have an id.Code samples (curl / TypeScript / one-click client install), schemas, and the live playground are on the pack page:
https://pipeworx.io/packs/china-pharma/
Pipeworx is an open MCP gateway connecting AI agents to live data. pipeworx.io